Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Marimed (MRMD) Gross Profit (2016 - 2025)

Historic Gross Profit for Marimed (MRMD) over the last 15 years, with Q3 2025 value amounting to $16.4 million.

  • Marimed's Gross Profit fell 249.67% to $16.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $60.4 million, marking a year-over-year decrease of 1042.68%. This contributed to the annual value of $62.9 million for FY2024, which is 462.84% down from last year.
  • Per Marimed's latest filing, its Gross Profit stood at $16.4 million for Q3 2025, which was down 249.67% from $16.0 million recorded in Q2 2025.
  • Marimed's Gross Profit's 5-year high stood at $19.4 million during Q2 2021, with a 5-year trough of $12.9 million in Q4 2024.
  • In the last 5 years, Marimed's Gross Profit had a median value of $16.4 million in 2025 and averaged $16.1 million.
  • In the last 5 years, Marimed's Gross Profit soared by 21512.78% in 2021 and then tumbled by 2544.32% in 2024.
  • Over the past 5 years, Marimed's Gross Profit (Quarter) stood at $15.5 million in 2021, then rose by 2.08% to $15.8 million in 2022, then increased by 9.52% to $17.3 million in 2023, then fell by 25.44% to $12.9 million in 2024, then rose by 26.74% to $16.4 million in 2025.
  • Its Gross Profit was $16.4 million in Q3 2025, compared to $16.0 million in Q2 2025 and $15.1 million in Q1 2025.